Sale!

Oncomine Comprehensive Myeloid Panel Test

6,400 د.إ

-36%

The Oncomine Comprehensive Myeloid Panel Test is a cutting-edge diagnostic tool designed to provide a comprehensive genetic analysis of myeloid cancers. This innovative test, available at DNA Labs UAE, leverages next-generation sequencing technology to examine a wide array of genetic mutations associated with various myeloid malignancies, including leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. By analyzing the genetic blueprint of a patient’s cancer, the Oncomine Comprehensive Myeloid Panel Test helps healthcare professionals to tailor personalized treatment plans, predict disease progression, and identify potential therapeutic targets.

Priced at 6400 AED, this test represents a significant investment in the precision and personalization of cancer care. Despite the cost, the value derived from the detailed insights into the genetic underpinnings of an individual’s cancer can be pivotal in guiding treatment decisions, potentially improving outcomes and quality of life for patients with myeloid malignancies. DNA Labs UAE, a reputable facility known for its advanced diagnostic services, ensures that the Oncomine Comprehensive Myeloid Panel Test is conducted with the highest standards of accuracy and reliability, offering patients and healthcare providers a crucial tool in the fight against myeloid cancers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOMINE COMPREHENSIVE MYELOID PANEL Test

Test Name: ONCOMINE COMPREHENSIVE MYELOID PANEL Test

Components: ABL1, ASXL1, BCOR, BAALC, BRAF, CALR, CEBPA, CBL, CSF3R, DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2,IKZF1, JAK2, KIT, KRAS, MPL, MYD88,MYC, NPM1, NRAS,NF1, PTPN11,PHF6, PRPF8, RB1, RUNX1, SETBP1, SF3B1, SRSF2,SH2B3, SMC1A, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2, FUSION GENE -ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6, FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A, MLLT3, MLLT10, MECOM, MET, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM15, RUNX1, TCF3, TFE3

Price: 6400.0 AED

Sample Condition: 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory.

Report Delivery: Sample by 1st / 16th of every month; Report 15th / 30th of Same month

Method: NGS

Test type: Leukemia

Doctor: Hematologist, Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled NGS Test Requisition Formis mandatory.

Test Details: The Oncomine Comprehensive Myeloid Panel Test is a genetic test that analyzes a patient’s DNA to detect mutations that are commonly associated with myeloid disorders, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and chronic myeloid leukemia (CML). The test uses next-generation sequencing technology to analyze a panel of genes that are known to be involved in the development and progression of myeloid disorders. The results of the test can help clinicians to diagnose and classify myeloid disorders, as well as to determine the most appropriate treatment options for individual patients.

Test Name ONCOMINE COMPREHENSIVE MYELOID PANEL Test
Components ABL1, ASXL1, BCOR, BAALC, BRAF, CALR, CEBPA, CBL, CSF3R, DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2,IKZF1, JAK2, KIT, KRAS, MPL, MYD88,MYC, NPM1, NRAS,NF1, PTPN11,PHF6, PRPF8, RB1, RUNX1, SETBP1, SF3B1, SRSF2,SH2B3, SMC1A, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2,FUSION GENE -ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6, FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A, MLLT3, MLLT10, MECOM, MET, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM15, RUNX1, TCF3, TFE3
Price 6400.0 AED
Sample Condition 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory.
Report Delivery Sample by 1st / 16th of every month; Report 15th / 30th of Same month
Method NGS
Test type Leukemia
Doctor Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

The Oncomine Comprehensive Myeloid Panel Test is a genetic test that analyzes a patient’s DNA to detect mutations that are commonly associated with myeloid disorders, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and chronic myeloid leukemia (CML). The test uses next-generation sequencing technology to analyze a panel of genes that are known to be involved in the development and progression of myeloid disorders. The results of the test can help clinicians to diagnose and classify myeloid disorders, as well as to determine the most appropriate treatment options for individual patients.